Exagen Inc.
Records under this name other than the patents Exagen Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 2 of 2 · Back to Exagen Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,563,590 | Methods of Quantifying Methotrexate Metabolites Term ended Term ended Jan 23, 2025 · High confidence | Term ended | Term ended Jan 23, 2025 | High confidence |
| US 6,921,667 | Methods for Direct Detection of Individual Methotrexate Metabolites Term ended Term ended May 22, 2023 · High confidence | Term ended | Term ended May 22, 2023 | High confidence |